A tweaked version of a cellular immunotherapy that recognizes mutations in a patient’s tumor has led to the complete regression of metastatic breast cancer in a woman whose disease had failed to respond to multiple lines of chemotherapy, a study reports. The therapy is being tested in a Phase 2 clinical trial (NCT01174121) at the … Continue reading Immunotherapy Targeting Tumor Mutations Leads to Complete Response in Advanced Breast Cancer Patient, NIH Reports